Fighting a class action that claims the age pension discriminates against Indigenous Australians because of differences in life expectancy, the Commonwealth says the rate of welfare dependency among Aboriginal and Torres Strait Islanders could impact the case.
Alleged war criminal Ben Roberts-Smith has won a bid to call a troop commander known as Person 81 in his defamation trial against Fairfax Media, despite the media company’s objections.
The High Court has dismissed Crown Resorts’ bid for special leave to appeal in a $100 million dispute over GST assessments on commissions and rebates paid to tour operators that directed international VIP gamblers to two of its casinos.
The state of Queensland has brought a “hopeless” defence in a $2.5 million suit alleging a Federal Circuit judge unlawfully imprisoned a Queensland man for contempt after he failed to comply with an order for particulars, a court has heard.
The High Court has been asked to wade into the debate over whether artificial intelligence can be named as an inventor on patent applications, after the Full Court overturned a landmark victory for AI pioneer Dr Stephen Thaler.
Ben Roberts-Smith, who is suing Fairfax for defamation, has lost an appeal of a judge’s decision refusing cross-examination of his ex-wife over allegations she accessed his private emails.
Mosaic Brands has lost its appeal of a ruling ordering it to comply with a request for documents from the Australian Communications and Media Authority over alleged violations of the Spam Act.
One Nation chief-of-staff James Ashby has failed to revive his lawsuit alleging the federal government breached the Fair Work Act by not paying his $4.5 million legal bill stemming from a dropped sexual harassment case against former House speaker Peter Slipper.
The corporate regulator has taken Australian Mines to court after its managing director was allegedly caught lying at an investment conference about the value of an offtake agreement and funding for a project at its cobalt and nickel mine in Queensland.
Bayer has dropped its appeal to a ruling that quashed an extension for its patent covering an oral contraceptive, after the Full Court dealt drug makers a blow in two separate cases on how patent term extensions should be calculated.